Celularity Statistics
Total Valuation
Celularity has a market cap or net worth of $37.77 million. The enterprise value is $106.70 million.
Important Dates
The last earnings date was Friday, December 6, 2024, after market close.
| Earnings Date | Dec 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Celularity has 22.48 million shares outstanding. The number of shares has increased by 26.65% in one year.
| Current Share Class | 22.48M |
| Shares Outstanding | 22.48M |
| Shares Change (YoY) | +26.65% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 15.67% |
| Owned by Institutions (%) | 14.99% |
| Float | 9.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| Forward PS | n/a |
| PB Ratio | 2.14 |
| P/TBV Ratio | 122.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19, with a Debt / Equity ratio of 4.00.
| Current Ratio | 0.19 |
| Quick Ratio | 0.12 |
| Debt / Equity | 4.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.81 |
Financial Efficiency
Return on equity (ROE) is -147.50% and return on invested capital (ROIC) is -28.09%.
| Return on Equity (ROE) | -147.50% |
| Return on Assets (ROA) | -17.45% |
| Return on Invested Capital (ROIC) | -28.09% |
| Return on Capital Employed (ROCE) | -75.80% |
| Revenue Per Employee | $401,667 |
| Profits Per Employee | -$292,100 |
| Employee Count | 120 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 3.88 |
Taxes
In the past 12 months, Celularity has paid $10,000 in taxes.
| Income Tax | 10,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.26% in the last 52 weeks. The beta is 0.63, so Celularity's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -64.26% |
| 50-Day Moving Average | 2.19 |
| 200-Day Moving Average | 2.67 |
| Relative Strength Index (RSI) | 37.21 |
| Average Volume (20 Days) | 182,646 |
Short Selling Information
The latest short interest is 171,657, so 0.76% of the outstanding shares have been sold short.
| Short Interest | 171,657 |
| Short Previous Month | 259,605 |
| Short % of Shares Out | 0.76% |
| Short % of Float | 1.73% |
| Short Ratio (days to cover) | 2.30 |
Income Statement
In the last 12 months, Celularity had revenue of $48.20 million and -$35.05 million in losses. Loss per share was -$1.66.
| Revenue | 48.20M |
| Gross Profit | 30.95M |
| Operating Income | -39.92M |
| Pretax Income | -196.29M |
| Net Income | -35.05M |
| EBITDA | -31.58M |
| EBIT | -39.92M |
| Loss Per Share | -$1.66 |
Full Income StatementBalance Sheet
The company has $133,000 in cash and $69.06 million in debt, giving a net cash position of -$68.93 million or -$3.07 per share.
| Cash & Cash Equivalents | 133,000 |
| Total Debt | 69.06M |
| Net Cash | -68.93M |
| Net Cash Per Share | -$3.07 |
| Equity (Book Value) | 17.28M |
| Book Value Per Share | 0.79 |
| Working Capital | -61.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.34 million and capital expenditures -$685,000, giving a free cash flow of -$13.02 million.
| Operating Cash Flow | -12.34M |
| Capital Expenditures | -685,000 |
| Free Cash Flow | -13.02M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
Gross margin is 64.20%, with operating and profit margins of -82.83% and -72.72%.
| Gross Margin | 64.20% |
| Operating Margin | -82.83% |
| Pretax Margin | -72.70% |
| Profit Margin | -72.72% |
| EBITDA Margin | -65.52% |
| EBIT Margin | -82.83% |
| FCF Margin | n/a |